Clinical Trial Update: Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated adding Herceptin (trastuzumab) to standard chemotherapy in the neoadjuvant treatment of operable breast cancer. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED